Clearside Biomedical Profit Margin

Clearside Biomedical (CLSD) currently reports a profit margin of -2602.2% as of September 2025. That compares with -413.83% in the prior-year period — down 528.8% year over year. That is below the Healthcare sector average of 13.89%. Use the charts on this page to explore Clearside Biomedical's profit margin history and peer comparisons.

Clearside Biomedical's profit margin decreased from -413.83% to -2602.2% — a 528.8% year-over-year decrease (period ending September 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Clearside Biomedical's profit margin of -2602.2% is lower than the Healthcare sector average of 13.89%. That is roughly 18830.2% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Clearside Biomedical's current -2602.2% should be judged against Healthcare norms (sector average: 13.89%) and against CLSD's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -2602.2%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.89%. From there, open related valuation or income-statement pages for Clearside Biomedical, and consider following CLSD for alerts when major investors trade the stock.